4ODF | Co-Crystal Structure of MDM2 with Inhibitor Compound 47 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Shaffer, P.L., Huang, X., Yakowec, P., Long, A.M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 | ||||||||||||
ligand | 2U1 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres., Gonzalez AZ, Li Z, Beck HP, Canon J, Chen A, Chow D, Duquette J, Eksterowicz J, Fox BM, Fu J, Huang X, Houze J, Jin L, Li Y, Ling Y, Lo MC, Long AM, McGee LR, McIntosh J, Oliner JD, Osgood T, Rew Y, Saiki AY, Shaffer P, Wortman S, Yakowec P, Yan X, Ye Q, Yu D, Zhao X, Zhou J, Olson SH, Sun D, Medina JC, J Med Chem. 2014 Mar 27. PMID:24601644 |
Data retrieval |
View 4ODF in 3D |
Visual 3D analysis of 4ODF |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4ODF |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |